CanSino Biologics, Pharmaceutical enterprise in Tianjin, China
CanSino Biologics is a pharmaceutical company based in Tianjin that specializes in developing and producing vaccines and biological products for international markets. The company runs production facilities and research laboratories where new immunological solutions against infectious diseases are created.
The company was founded in 2009 and gained international attention through the development of Convidecia, a vaccine against COVID-19. This single-dose vaccine contributed to the worldwide fight against the pandemic.
This Chinese pharmaceutical corporation maintains research partnerships with national institutions, including the Beijing Institute of Biotechnology and Academy of Military Medical Sciences.
The company uses adenovirus vector technology to produce vaccines, allowing new products to be developed relatively quickly. This method enables the production of immunological solutions for different infectious diseases.
The company developed an inhalable form of the COVID-19 vaccine that is administered through the respiratory system. This delivery method offers an alternative to the conventional injection into the muscle.
The community of curious travelers
AroundUs brings together thousands of curated places, local tips, and hidden gems, enriched daily by 60,000 contributors worldwide.
